0.9434
Io Biotech Inc stock is traded at $0.9434, with a volume of 449.42K.
It is down -9.48% in the last 24 hours and up +95.31% over the past month.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
See More
Previous Close:
$1.04
Open:
$1.03
24h Volume:
449.42K
Relative Volume:
0.08
Market Cap:
$62.14M
Revenue:
-
Net Income/Loss:
$-86.08M
P/E Ratio:
-0.4373
EPS:
-2.1574
Net Cash Flow:
$-72.06M
1W Performance:
+3.58%
1M Performance:
+95.31%
6M Performance:
-7.71%
1Y Performance:
-21.55%
Io Biotech Inc Stock (IOBT) Company Profile
Name
Io Biotech Inc
Sector
Industry
Phone
(457) 070-2980
Address
OLE MAALOES VEH 3, COPENHAGEN
Compare IOBT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
IOBT
Io Biotech Inc
|
0.9432 | 68.52M | 0 | -86.08M | -72.06M | -2.1574 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.60 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
636.50 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.88 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.71 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.01 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Io Biotech Inc Stock (IOBT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-30-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Sep-30-25 | Downgrade | TD Cowen | Buy → Hold |
Io Biotech Inc Stock (IOBT) Latest News
Sector ETF performance correlation with IO Biotech Inc.Risk Management & Real-Time Volume Analysis Alerts - newser.com
Will IO Biotech Inc. see short term momentumMarket Risk Analysis & Growth Focused Stock Reports - newser.com
Will IO Biotech Inc. stock deliver long term returnsAnalyst Downgrade & Daily Volume Surge Signals - newser.com
Can IO Biotech Inc. stock sustain market leadershipTrade Performance Summary & Low Volatility Stock Suggestions - newser.com
Is IO Biotech Inc. stock a top momentum playJobs Report & AI Driven Stock Movement Reports - newser.com
Is IO Biotech Inc. stock entering bullish territory2025 Sector Review & Safe Investment Capital Preservation Plans - newser.com
Leading vs lagging indicators on IO Biotech Inc. performance2025 Volume Leaders & Accurate Technical Buy Alerts - newser.com
What moving averages say about IO Biotech Inc.2025 Volume Leaders & Expert Curated Trade Ideas - newser.com
IO Biotech Inc Stock Analysis and ForecastEvening Star Patterns & Affordable Trading Growth - earlytimes.in
Is IO Biotech Inc. meeting your algorithmic filter criteriaMarket Performance Recap & Growth Focused Stock Pick Reports - newser.com
Will IO Biotech Inc. stock outperform tech sector in 2025Gap Down & Real-Time Stock Entry Alerts - newser.com
Can technical indicators confirm IO Biotech Inc.’s reversalQuarterly Profit Report & Daily Growth Stock Tips - newser.com
How hedge fund analytics apply to IO Biotech Inc. stock2025 AllTime Highs & Safe Entry Point Alerts - newser.com
IO Biotech Inc. recovery potential after sell offPortfolio Performance Summary & Fast Moving Stock Trade Plans - newser.com
Will IO Biotech Inc. stock gain from government policiesGDP Growth & Daily Entry Point Trade Alerts - newser.com
Is IO Biotech Inc. stock near bottom after decline2025 Top Gainers & Daily Chart Pattern Signal Reports - newser.com
Layoff Tracker: Sensei Plans To Cut Workforce While Considering Strategic Alternatives - BioSpace
Io Biotech Inc Stock (IOBT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):